ESREBOXETINE
UNII L8S50ZY490

Substance Identification & Data

This profile provides standardized clinical and technical data for Esreboxetine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) L8S50ZY490.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 98819-76-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

L8S50ZY490

CAS Registry Number

98819-76-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ESREBOXETINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C19H23NO3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

CBQGYUDMJHNJBX-OALUTQOASA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C175719

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

65856

Unique identification number in the NCBI database of chemical substances.

INN ID

8997

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

TT-93

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1ccc(c(OCC)c1)O[C@H]([C@]2(OCCNC2)[H])c3ccccc3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Esreboxetine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.